Cidara Therapeutics Statistics

Total Valuation

CDTX has a market cap or net worth of $212.83 million. The enterprise value is $47.35 million.

Market Cap	212.83M
Enterprise Value	47.35M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CDTX has 10.95 million shares outstanding. The number of shares has increased by 93.71% in one year.

Current Share Class	10.95M
Shares Outstanding	10.95M
Shares Change (YoY)	+93.71%
Shares Change (QoQ)	+45.74%
Owned by Insiders (%)	0.95%
Owned by Institutions (%)	17.21%
Float	3.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	704.72
Forward PS	n/a
PB Ratio	1.67
P/TBV Ratio	1.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	156.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.02.

Current Ratio	3.87
Quick Ratio	3.48
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -299.58% and return on invested capital (ROIC) is -102.83%.

Return on Equity (ROE)	-299.58%
Return on Assets (ROA)	-55.20%
Return on Invested Capital (ROIC)	-102.83%
Return on Capital Employed (ROCE)	-75.53%
Revenue Per Employee	$7,947
Profits Per Employee	-$4.82M
Employee Count	38
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.79% in the last 52 weeks. The beta is 0.86, so CDTX's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+59.79%
50-Day Moving Average	20.80
200-Day Moving Average	17.52
Relative Strength Index (RSI)	45.14
Average Volume (20 Days)	94,554

Short Selling Information

The latest short interest is 452,539, so 4.13% of the outstanding shares have been sold short.

Short Interest	452,539
Short Previous Month	480,028
Short % of Shares Out	4.13%
Short % of Float	12.66%
Short Ratio (days to cover)	2.28

Income Statement

In the last 12 months, CDTX had revenue of $302,000 and -$182.98 million in losses. Loss per share was -$20.89.

Revenue	302,000
Gross Profit	-71.58M
Operating Income	-107.95M
Pretax Income	-36.02M
Net Income	-182.98M
EBITDA	-107.79M
EBIT	-107.95M
Loss Per Share	-$20.89

Full Income Statement

Balance Sheet

The company has $168.15 million in cash and $2.67 million in debt, giving a net cash position of $165.48 million or $15.11 per share.

Cash & Cash Equivalents	168.15M
Total Debt	2.67M
Net Cash	165.48M
Net Cash Per Share	$15.11
Equity (Book Value)	141.68M
Book Value Per Share	11.60
Working Capital	140.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$191.84 million and capital expenditures -$106,000, giving a free cash flow of -$191.95 million.

Operating Cash Flow	-191.84M
Capital Expenditures	-106,000
Free Cash Flow	-191.95M
FCF Per Share	-$17.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-35,743.71%
Pretax Margin	-61,454.97%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CDTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.71%
Shareholder Yield	-93.71%
Earnings Yield	-85.98%
FCF Yield	-90.19%

Analyst Forecast

The average price target for CDTX is $38.50, which is 98.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.50
Price Target Difference	98.15%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	150.22%
EPS Growth Forecast (5Y)	-50.02%

Stock Forecasts

Stock Splits

The last stock split was on April 24, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 24, 2024
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1